Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
ACS Chem Biol
2013 Jan 01;86:1344-51. doi: 10.1021/cb300674x.
Show Gene links
Show Anatomy links
Mammalian neuronal sodium channel blocker μ-conotoxin BuIIIB has a structured N-terminus that influences potency.
Kuang Z
,
Zhang MM
,
Gupta K
,
Gajewiak J
,
Gulyas J
,
Balaram P
,
Rivier JE
,
Olivera BM
,
Yoshikami D
,
Bulaj G
,
Norton RS
.
???displayArticle.abstract???
Among the μ-conotoxins that block vertebrate voltage-gated sodium channels (VGSCs), some have been shown to be potent analgesics following systemic administration in mice. We have determined the solution structure of a new representative of this family, μ-BuIIIB, and established its disulfide connectivities by direct mass spectrometric collision induced dissociation fragmentation of the peptide with disulfides intact. The major oxidative folding product adopts a 1-4/2-5/3-6 pattern with the following disulfide bridges: Cys5-Cys17, Cys6-Cys23, and Cys13-Cys24. The solution structure reveals that the unique N-terminal extension in μ-BuIIIB, which is also present in μ-BuIIIA and μ-BuIIIC but absent in other μ-conotoxins, forms part of a short α-helix encompassing Glu3 to Asn8. This helix is packed against the rest of the toxin and stabilized by the Cys5-Cys17 and Cys6-Cys23 disulfide bonds. As such, the side chain of Val1 is located close to the aromatic rings of Trp16 and His20, which are located on the canonical helix that displays several residues found to be essential for VGSC blockade in related μ-conotoxins. Mutations of residues 2 and 3 in the N-terminal extension enhanced the potency of μ-BuIIIB for NaV1.3. One analogue, [d-Ala2]BuIIIB, showed a 40-fold increase, making it the most potent peptide blocker of this channel characterized to date and thus a useful new tool with which to characterize this channel. On the basis of previous results for related μ-conotoxins, the dramatic effects of mutations at the N-terminus were unanticipated and suggest that further gains in potency might be achieved by additional modifications of this region.
Berman,
The Protein Data Bank.
2000,
Pubmed
Bhattacharyya,
Rapid mass spectrometric determination of disulfide connectivity in peptides and proteins.
2013,
Pubmed
Bulaj,
Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels.
2005,
Pubmed
Catterall,
International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels.
2005,
Pubmed
Cruz,
Conus geographus toxins that discriminate between neuronal and muscle sodium channels.
1985,
Pubmed
Cummins,
The roles of sodium channels in nociception: Implications for mechanisms of pain.
2007,
Pubmed
Dib-Hajj,
Sodium channels in normal and pathological pain.
2010,
Pubmed
Favreau,
A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors.
2012,
Pubmed
,
Xenbase
French,
Sodium channel toxins--receptor targeting and therapeutic potential.
2004,
Pubmed
French,
The tetrodotoxin receptor of voltage-gated sodium channels--perspectives from interactions with micro-conotoxins.
2010,
Pubmed
Green,
Conotoxins containing nonnatural backbone spacers: cladistic-based design, chemical synthesis, and improved analgesic activity.
2007,
Pubmed
Gupta,
Disulfide bond assignments by mass spectrometry of native natural peptides: cysteine pairing in disulfide bonded conotoxins.
2010,
Pubmed
Han,
Conus venoms - a rich source of peptide-based therapeutics.
2008,
Pubmed
Holford,
Pruning nature: Biodiversity-derived discovery of novel sodium channel blocking conotoxins from Conus bullatus.
2009,
Pubmed
,
Xenbase
Keizer,
Structural basis for tetrodotoxin-resistant sodium channel binding by mu-conotoxin SmIIIA.
2003,
Pubmed
Khoo,
Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.
2009,
Pubmed
,
Xenbase
Khoo,
Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.
2011,
Pubmed
,
Xenbase
Khoo,
Distinct disulfide isomers of μ-conotoxins KIIIA and KIIIB block voltage-gated sodium channels.
2012,
Pubmed
Lewis,
Isolation and structure-activity of mu-conotoxin TIIIA, a potent inhibitor of tetrodotoxin-sensitive voltage-gated sodium channels.
2007,
Pubmed
,
Xenbase
Li,
Molecular basis of isoform-specific micro-conotoxin block of cardiac, skeletal muscle, and brain Na+ channels.
2003,
Pubmed
Markgraf,
Mechanism and molecular basis for the sodium channel subtype specificity of µ-conopeptide CnIIIC.
2012,
Pubmed
McArthur,
Interactions of key charged residues contributing to selective block of neuronal sodium channels by μ-conotoxin KIIIA.
2011,
Pubmed
Nielsen,
Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels.
2002,
Pubmed
Norton,
Conotoxins down under.
2006,
Pubmed
Norton,
Mu-conotoxins as leads in the development of new analgesics.
2010,
Pubmed
Pallaghy,
Three-dimensional structure in solution of the calcium channel blocker omega-conotoxin.
1993,
Pubmed
Poppe,
PADLOC: a powerful tool to assign disulfide bond connectivities in peptides and proteins by NMR spectroscopy.
2012,
Pubmed
Safo,
Distinction among neuronal subtypes of voltage-activated sodium channels by mu-conotoxin PIIIA.
2000,
Pubmed
,
Xenbase
Shon,
mu-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes.
1998,
Pubmed
Stevens,
Design of bioactive peptides from naturally occurring μ-conotoxin structures.
2012,
Pubmed
,
Xenbase
Terlau,
Conus venoms: a rich source of novel ion channel-targeted peptides.
2004,
Pubmed
Ulrich,
BioMagResBank.
2008,
Pubmed
Venkatachalam,
Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units.
1968,
Pubmed
West,
Mu-conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons.
2002,
Pubmed
Wilson,
μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve.
2011,
Pubmed
,
Xenbase
Yao,
Structure, dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA.
2008,
Pubmed
,
Xenbase
Zhang,
μ-conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltage-gated sodium channels.
2010,
Pubmed
,
Xenbase
Zhang,
Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin.
2010,
Pubmed
,
Xenbase
Zhang,
Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.
2007,
Pubmed
,
Xenbase
Zhang,
Synergistic and antagonistic interactions between tetrodotoxin and mu-conotoxin in blocking voltage-gated sodium channels.
2009,
Pubmed
,
Xenbase